# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Breast Cancer

Cancer, Breast
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 81-90 of 2380 results.
Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer
Status: Recruiting
Last Changed: Aug 10, 2012
First Received: Aug 10, 2012
Disease(s): Breast Cancer
Intervention(s): Xeloda
Locations: Tianjin Cancer Hospital, Tianjin, Tianjin, China
Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PET
Status: Recruiting
Last Changed: Jul 15, 2020
First Received: Oct 10, 2014
Disease(s): Breast Cancer
Intervention(s): Arm B, tumor markers assessment
Locations: Azienda Sanitaria dell'Alto Adige - Ospedale di Bressanone, Bressanone, Bolzano, Italy
Azienda Sanitaria dell'Alto Adige - Ospedale di Merano, Merano, Bolzano, Italy
ASL13 - Presidio Ospedaliero Mirano, U.O.C. Oncologia ed Ematologia Oncologica, Mirano, Venezia, Italy
Azienda Ospedaliero-Universitaria di Bologna, Policlinico S. Orsola-Malpighi, SSD Oncologia Medica Addarii, Bologna, Italy
Azienda Sanitaria dell'Alto Adige - Ospedale Centrale di Bolzano, Bolzano, Italy
... and 3 other locations.
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
Status: Recruiting
Last Changed: Jun 17, 2019
First Received: Jun 26, 2018
Disease(s): HER2 Negative Breast Cancer
Intervention(s): Response monitoring (no intervention)
Locations: University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States
Increasing African Immigrant Women's Participation in Breast Cancer Screening
Status: Recruiting
Last Changed: Jul 31, 2020
First Received: Jun 29, 2020
Disease(s): Breast Cancer
Intervention(s): African Immigrant Breast Cancer Education Program
Locations: Icahn School of Medicine at Mount Sinai, New York, New York, United States
Evaluating and Following Breast Cancer Patients in a Better Way
Status: Not yet recruiting
Last Changed: Feb 05, 2019
First Received: Feb 05, 2019
Disease(s): Breast Cancer Female
Intervention(s): clinical and physical assessment
Vacuum Assisted Biopsy Immediately Before Surgery as an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast Cancer
Status: Recruiting
Last Changed: Jul 07, 2020
First Received: Feb 28, 2020
Disease(s): Breast Cancer
Intervention(s): Vacuum assisted biopsy (VAB)
Locations: Kantonsspital Baden, Baden, Switzerland
Universitätsspital Basel, Basel, Switzerland
Bethesda Spital, Basel, Switzerland
IOSI - Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland
Inselspital - Universitätsklinik für Frauenklinik, Bern, Switzerland
... and 12 other locations.
Long-term Effects of Breast Cancer Treatment
Status: Not yet recruiting
Last Changed: Mar 26, 2019
First Received: Mar 15, 2019
Disease(s): Breast Cancer
A Window-of-opportunity Study of Pelareorep in Early Breast Cancer
Status: Recruiting
Last Changed: Jun 22, 2020
First Received: Sep 25, 2019
Disease(s): Breast Cancer
Intervention(s): Pelareorep, Letrozole, Atezolizumab, Trastuzumab
Locations: ICO Badalona, Badalona, Spain
Hospital Clínic de Barcelona, Barcelona, Spain
Hospital Quirón Dexeus, Barcelona, Spain
Hospital Moisés Broggi, Esplugues De Llobregat, Spain
Hospital Fuenlabrada, Madrid, Spain
... and 10 other locations.
Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer
Status: Recruiting
Last Changed: May 08, 2020
First Received: Aug 02, 2017
Disease(s): Breast Cancer
Intervention(s): Pembrolizumab, High-intensity focused ultrasound (HIFU)
Locations: University of Virginia, Charlottesville, Virginia, United States
Olaparib in Combination With Vorinostat in Patients With Relapsed/Refractory and/or Metastatic Breast Cancer
Status: Not yet recruiting
Last Changed: May 15, 2020
First Received: Nov 15, 2018
Disease(s): Breast Cancer Metastatic, Breast Cancer
Intervention(s): Olaparib, Vorinostat
Locations: Houston Methodist Cancer Center, Houston, Texas, United States